Is oestrogen therapy justified in the treatment of hereditary haemorrhagic telangiectasia: A biochemical evaluation

Clinical Otolaryngology and Allied Sciences

Volumn 25, Issue 6, 2000, Pages 547-550

  Pau, Henry ^a,c   Carney, A S ^a   Walker, R ^b   Murty, G E ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Hereditary haemorrhagic telangiectasia; Oestrogen

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FORMALDEHYDE; PARAFFIN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE;

ADMINISTRATION, INTRANASAL; ANTIBODIES; ANTIBODIES, MONOCLONAL; EPISTAXIS; ESTROGENS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NASAL MUCOSA; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 0034536958     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2000.00415.x     Document Type: Article

References (53)

1. Hereditary epistaxis
2. Multiple hereditary telangiectasia causing hemorrhage (Hereditary Hemorrhagic Telangiectasia)
3. Rendu-Osler-Weber disease: A triple eponymous title lives on
4. Epistaxis repetes chez un sujet porteur de petits angiomes cutanes et muqueux
5. Epistaxis repetes chez un sujet porteur de petits angiomes cutanes et muqueux
6. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes
7. On multiple haemorrhagic telangiectases with recurring haemorrhages
8. Multiple hereditary development angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages
9. Hormonal management of hereditary hemorrhagic telangiectasia
10. Screening of family members of patients with hereditary hemorrhagic telangiectasia
11. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): New insights in pathogenesis, complications and treatment
12. The natural history of epistaxis in hereditary hemorrhagic telangiectasia
13. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu Disease)
14. Clinical manifestations of hereditary haemorrhagic telangiectasia
15. Percutaneous embolisation for control of nasal blood circulation
16. Therapeutic percutaneous embolisation in intractable epistaxis
17. Place of embolisation in the treatment of severe epistaxis
18. Percutaneous embolisation to control epistaxis in Rendu-Osler-Weber disease
19. Therapeutic embolisation for control of epistaxis in a patient with hereditary haemorrhagic telangiectasia
20. Laser photocoagulation in the care of patients with Osler-Weber-Rendu disease: Operative technique
21. Retrospective study of the role of the argon laser in the management of epistaxis
22. Treatment of hereditary haemorrhagic telangiectasia by Nd-YAG laser photocoagulation
23. Neodynium-Yag laser intranasal photocoagulation in hereditary haemorrhagic telangiectasia: An update report
24. Fiberoptic bronchoscope and Nd-YAG laser treatment of severe epistaxis from nasal hereditary hemorrhagic telangiectasia and hemangioma
25. Management of epistaxis in Rendu-Osler disease: Is brachytherapy effective?
26. Hereditary hemorrhagic telangiectasia: What the otolaryngologist should know
27. Management of epistaxis in hereditary hemorrhagic telangiectasia: Review of 80 cases
28. Amniotic graft in the management of severe epistaxis due to hereditary haemorrhagic telangiectasia
29. Septal dermoplasty for control of nosebleeds in hereditary haemorrhagic telangiectasia
30. Long-term results of dermoplasty in the treatment of hereditary haemorrhagic telangiectasia
31. Use of human amniotic membrane in otolaryngologic practice
32. A new technique using cultured epithelial sheets for the management of epistaxis associated with hereditary haemorrhagic telangiectasia
33. Microvascular free flap in hereditary hemorrhagic telangiectasia
34. The management of severe epistaxis due to hereditary haemorrhagic telangiectasia using regional facial cutaneous flaps
35. Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia
36. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia
37. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): An electron microscopic study of the vascular lesions before and after therapy with hormones
38. The human respiratory nasal mucosa in females using contraceptive pills: An ultramicroscopic and histochemical study
39. Familial hemorrhagic telangiectasia
40. Use of estrogen in treatment of familial hemorrhagic telangiectasia
41. Long-term treatment of epistaxis with oestrogen
42. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): Management of epistaxis in nine patients using systemic hormone therapy
43. Estrogen treatment of hereditary hemorrhagic telangiectasia
44. Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasia
45. Hereditary hemorrhagic telangiectasia and Danazol
46. Local oestrogen for recurrent epistaxis caused by familial telangiectasia: A letter
47. Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa
48. Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
49. The estrogen receptor family
50. Oestrogen receptors: An overview
51. Use of oestrogen in treatment of familial haemorrhagic telangiectasia
52. Familial epistais